- Cholangiocarcinoma arising in von Meyenburg complexes
-
Kim HK, Jin SY
- KMID: 1015577
- Korean J Hepatol.
- 2011 Jun;17(2):161-164.
- doi: 10.3350/kjhep.2011.17.2.161
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Inflammatory Pseudotumor of the Liver Treated by Hepatic Resection: A Case Report
-
Kim YW, Lee JG, Kim KS, Yoon DS, Lee WJ, Kim BR, Shin EA, Park YN, Choi JS
- KMID: 1715885
- Yonsei Med J.
- 2006 Feb;47(1):140-143.
- doi: 10.3349/ymj.2006.47.1.140
Inflammatory pseudotumor (IPT) of the liver is rare benign tumor. When the diagnosis of IPT is established with biopsy, simple observation or conservative therapy is preferred because of the possibility... -
- CITED
-
- Close
- SHARE
-
- Close
- IgG4-Associated Cholangitis Can Mimic Hilar Cholangiocarcinoma
-
Zaydfudim , Wang AY, de Lange E, Zhao Z, Moskaluk C, Bauer TW, Adams RB
- KMID: 2160641
- Gut Liver.
- 2015 Jul;9(4):556-560.
- doi: 10.5009/gnl14241
IgG4-associated cholangitis can mimic hilar cholangiocarcinoma. Previously reported patients with IgG4-associated cholangitis mimicking cholangiocarcinoma had elevated serum IgG4 levels and long-segment biliary strictures. However, in the absence of other diagnostic... -
- CITED
-
- Close
- SHARE
-
- Close
- 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma
-
Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC)
- KMID: 2155520
- Korean J Radiol.
- 2015 Jun;16(3):465-522.
- doi: 10.3348/kjr.2015.16.3.465
The guideline for the management of hepatocellular carcinoma (HCC) was first developed in 2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer Center,... -
- CITED
-
- Close
- SHARE
-
- Close
- The Actual Five-year Survival Rate of Hepatocellular Carcinoma Patients after Curative Resection
-
Lee JG, Kang CM, Park JS, Kim KS, Yoon DS, Choi JS, Lee WJ, Kim BR
- KMID: 1715879
- Yonsei Med J.
- 2006 Feb;47(1):105-112.
- doi: 10.3349/ymj.2006.47.1.105
The five-year survival rate of patients after curative resection of hepatocellular carcinoma (HCC) has been reported to be 30 to 50 %, however the actual survival rate may be different.... -
- CITED
-
- Close
- SHARE
-
- Close
